We have documented that coverage policies vary by payer: private employer-sponsored plans are rapidly evolving (with 43% of large firms now covering GLP-1 weight drugs ( [6] )), Medicare is transitioning from outright exclusion to the BALANCE Model framework for coverage starting mid-2026 ( [5] ), and Medicaid coverage differs state by state with only 13 programs covering obesity indications as of early 2026 ( [3] ) ( [33] )
Learning to read probiotic labels to spot hidden fillers is one of the highest-leverage skills in supplement selection, and many people prefer filler-free probiotics without unnecessary additives
Maintaining adequate protein intake becomes particularly important during weight loss, as both fat and lean tissue can be lost
Common Side Effects The most common side effects of compounded semaglutide and compounded tirzepatide include nausea, vomiting, constipation, diarrhea, acid reflux, stomach pain, bloating, headaches, and fatigue
4.1.2 Limitations and research bottlenecks A major challenge in current research is the difficulty of decoupling the mediating effect of weight loss from the drugs direct pharmacological actions
Both are injections with strong evidence for weight loss